Background Several studies have reported DNA methylation in blood to be associated with body mass index (BMI), but few have investigated causal aspects of the association. We used a twin family design to assess this association at two life points and applied a novel analytical approach to appraise the evidence for causality. Methods The methylation profile of DNA from peripheral blood was measured for 479 Australian women from 130 twin families. Linear regression was used to estimate the associations of DNA methylation at~410,000 cytosine-guanine dinucleotides (CpGs), and of the average DNA methylation at~20,000 genes, with current BMI, BMI at age 18-21 years, and the change between the two (BMI change). A novel regression-based methodology for twins, Inference about Causation through Examination of Familial Confounding (ICE FALCON), was used to assess causation. Results At a 5% false discovery rate, nine, six and 12 CpGs at 24 loci were associated with current BMI, BMI at age 18-21 years and BMI change, respectively. The average DNA methylation of the BHLHE40 and SOCS3 loci was associated with current BMI, and of the PHGDH locus with BMI change. From the ICE FALCON analyses with BMI as the predictor and DNA methylation as the outcome, a woman's DNA methylation level was associated with her co-twin's BMI, and the association disappeared after conditioning on her own BMI, consistent with BMI causing DNA methylation. To the contrary, using DNA methylation as the predictor and BMI as the outcome, a woman's BMI was not associated with her co-twin's DNA methylation level, consistent with DNA methylation not causing BMI. Conclusion For middle-aged women, peripheral blood DNA methylation at several genomic locations is associated with current BMI, BMI at age 18-21 years and BMI change. Our study suggests that BMI has a causal effect on peripheral blood DNA methylation.
Inference about causation between body mass index and DNA methylation in blood from a twin family study 
Introduction
DNA methylation, a natural process whereby a methyl group is typically added to a cytosine-guanine dinucleotide (CpG), modifies gene expression without changing DNA sequence. Sensitive to exposures and lifestyle factors associated with health, DNA methylation has been proposed to play a critical role in the etiology of complex traits and diseases [1, 2] . Several studies have investigated the association between DNA methylation in blood and obesity. Differences in DNA methylation have been observed between obese and lean people [3] [4] [5] [6] [7] . Epigenome-wide association studies (EWAS) have reported~500 CpGs to be differentially methylated in relation to body mass index (BMI) [8] [9] [10] [11] [12] [13] [14] [15] [16] . DNA methylation at some BMI-related CpGs has also been suggested to be associated with other obesity traits such as adult waist circumference [9, 10] and BMI change [10, 16] , and obesity-related traits such as type 2 diabetes [14, 17] and metabolic syndrome [12] .
Most of the reported associations are from crosssectional designs, thus the causal nature of the association, i.e. whether DNA methylation has a causal effect on BMI or vice versa, is unknown. There is also a possibility that the observed association is due to familial confounding [18] . Mendelian randomisation (MR) has been proposed as a method to assess causation [19] , and several studies have applied MR to make causal inference between BMI and DNA methylation [8, 13, 14] .
As well as requiring knowledge and measurement of genetic variants, the validity of MR depends on certain assumptions, some of which are difficult to verify and need to be given attention [20] . Especially in the context of BMI and DNA methylation, BMI-related genetic variants are potentially associated with DNA methylation through other obesity or metabolism pathways, which violates the assumption of no directional pleiotropy. Additionally, MR requires large-scale studies with genetic variants and DNA methylation data available for the same subjects, which might not be achievable. Obviously, other approaches for assessing causation are needed if using MR is not possible.
In this study, we aimed to investigate the association between BMI and blood DNA methylation, to replicate associations reported by previous EWAS, and to investigate the causal nature of the association using a regression-based approach to data for related individuals.
Subjects and methods

Study sample
The sample comprised women from the Australian Mammographic Density Twins and Sisters Study (AMDTSS) [21] . A telephone-administered questionnaire was used to collect self-reported demographic information, height, current weight at interview and recalled weight at age 18-21 years. A total of 479 women, including 66 monozygotic twin (MZ) pairs, 66 dizygotic twin (DZ) pairs and 215 of their sisters from 130 families was selected [22] . Of these, one was excluded due to her current reported BMI being an outlier. The study was approved by the Human Research Ethics Committee of the University of Melbourne. All subjects provided written informed consent.
BMI traits
We studied three BMI traits: current BMI, BMI at age 18-21 years and BMI change between the two time-points. Current BMI and BMI at age 18-21 years were calculated using height, and the reported weight at the corresponding age.
DNA methylation data
DNA was extracted from dried blood spots stored on Guthrie cards using a method previously described [23] . DNA was sodium bisulfite converted using the EZ DNA Methylation-Gold protocol as per manufacturers' instructions (Zymo Research, Irvine, CA) and eluted in 20 µl elution buffer. DNA methylation was measured using the Illumina Infinium HumanMethylation450 BeadChip (HM450) array. All laboratory work was performed at the Genetic Epidemiology Laboratory, University of Melbourne.
Raw intensity data were processed by the Bioconductor minfi package [24] , which included normalisation of data using Illumina's reference factor-based normalisation methods (preprocessIllumina) and subset-quantile within array normalisation (SWAN) [25] for type I and II probe bias correction. An empirical Bayes batch effects removal method, ComBat [26] , was applied to minimise the technical variation across batches. All samples passed quality control. Probes with missing value (detection P-value > 0.01) for one or more samples, with documented SNPs at the target CpG, binding to multiple locations [27] or binding to the X chromosome, and 65 control probes were excluded, leaving 411 394 probes remaining for analysis; see Li et al. [22] for more details. The data set was deposited on Gene Expression Omnibus under the accession number GSE100227.
Association analyses for CpG-specific DNA methylation
We used a linear regression model to investigate association between CpG-specific DNA methylation and BMI trait, in which the DNA methylation M-value (the logit transformation of the percentage of DNA methylation) was the outcome, and BMI trait was the predictor. The three BMI traits were analysed separately. Age and the proportions of six types of cells, including monocytes, B cells, natural killers, CD4+T cells, CD+8T cells and granulocytes, were adjusted for in the model as covariates. The cell proportions were estimated from the DNA methylation data using the Houseman method [28] .
To account for the relatedness between members within the same family, the model was fitted using the Generalised Estimating Equations (GEE) method with family as cluster. The GEE model was fitted using the geeglm() function from the R package geepack. The Wald test using the robust standard error was used for the statistical inference about the regression coefficient. To account for multiple testing, associations with a false discovery rate (FDR) [29] <0.05 were considered statistically significant.
Association analyses for gene-average DNA methylation
We investigated association between gene-average DNA methylation and BMI trait. We annotated CpGs to genes using the column 'UCSC_RefGene_Name' from the Illumina's annotation file, resulting in a total of 19 823 genes. For each gene, the average DNA methylation was calculated as the average Beta-value (the percentage of DNA methylation) across CpGs annotated to that gene. The geneaverage DNA methylation was then logit transformed and used in the analysis. The association was investigated using the same linear model as that for CpG analysis: with geneaverage DNA methylation as the outcome and BMI trait as predictor, and with age and cell proportions adjusted for as covariates. The model was fitted using GEE, and the Wald test using the robust standard error was also used for the statistical inference. Similarly, associations with a FDR < 0.05 were considered statistically significant.
Replication of previously reported CpGs and genes
After quality control, 462 CpGs and 332 genes at which there are CpGs previously reported to be associated with BMI [8] [9] [10] [11] [12] [13] [14] [15] [16] were included in the analysis. For these CpGs and genes, we examined their associations with current BMI. Results for the 462 CpGs and 332 genes were extracted from the genome-wide analysis results for CpG-specific DNA methylation and gene-average DNA methylation above, respectively. Associations for these CpGs and genes were then examined and those with a nominal P < 0.05 were considered replicated.
Causal inference analyses
We performed causal inference using Inference about Causation through Examination of FAmiliaL CONfounding (ICE FALCON), a regression-based methodology for analysing twin data [30] [31] [32] [33] [34] . By causal, it is meant that were it
Fig. 1 Some possible directed acyclic graphs for the different causation models that explain the cross-twin cross-trait correlation. a The cross-twin cross-trait correlation is due to familial confounding. b The cross-twin cross-trait correlation is due to the causal effect of X on Y. c The cross-twin cross-trait correlation is due to the causal effect of Y on X. X and Y denote two variables measured for pairs of twins, S X denotes the unmeasured genetic and non-genetic factors shared by twins that influence X only, S Y denotes the unmeasured genetic and non-genetic factors shared by twins that influence Y only, S XY denotes the unmeasured genetic and non-genetic factors shared by twins that influence both X and Y, C denotes the confounders between X and Y within an individual, 'self' refers to an individual and 'co-twin' refers to the individual's twin possible to vary a predictor measure experimentally then the expected value of the outcome measure would change. As shown in Figure 1 , suppose there are two variables, X and Y, measured for pairs of twins. Assume that X and Y are positively associated within an individual. Let S denote the unmeasured genetic and non-genetic factors that affect both twins; S X represents those factors that influence X values only, S Y those that influence Y values only, and S XY those that influence both X and Y values. For the purpose of explanation, let 'self' refer to an individual and 'co-twin' refer to the individual's twin, but recognise that these labels can be swapped and both twins within a pair are used in the analysis.
If there is a correlation between Y self and X co-twin , it might be due to a familial confounder, S XY (Fig. 1a) . It could also be due to X having a causal effect on Y within an individual, provided X self and X co-twin are correlated (Fig. 1b) , or to Y having a casual effect on X, provided Y self and Y co-twin are correlated (Fig. 1c) . Note that the confounders specific to an individual, C self and C co-twin , do not in themselves result in a correlation between Y self and X co-twin .
Using GEE to take into account any correlation in Y between twins within the same pair, we fit three models:
If the correlation between Y self and X co-twin is solely due to familial confounding (Fig. 1a) , the marginal association between Y self and X self (β self in Model 1) and the marginal association between Y self and X co-twin (β co-twin in Model 2) must both be non-zero. Adjusting for X self , the conditional association between Y self and X co-twin (β′ co-twin in Model 3) is expected to attenuate from β co-twin in Model 2 towards the null. Similarly, adjusting for X co-twin (Model 3), the conditional association between Y self and X co-twin (β′ self in Model 3) is expected to attenuate from β self towards the null.
If the correlation between Y self and X co-twin is solely due to a causal effect from X to Y (Fig. 1b) , by adjusting for X self the pathway between these two variables (the one through S X ) is blocked and the conditional association (β′ co-twin in Model 3) is expected to be null. Adjusting for X co-twin will have no influence on the pathway between Y self and X self , so the conditional association β′ self in Model 3 is expected to be β self in Model 1.
If the correlation between Y self and X co-twin is solely due to a causal effect from Y to X (Fig. 1c) , the pathway through X self is blocked due to X self as a collider, and the pathway through S Y is blocked due to the fact that GEE analysis, in effect, conditions on S Y , so there is no marginal association between Y self and X co-twin , and β co-twin of Model 2 is expected to be zero.
We applied ICE FALCON to CpGs reported by Wahl et al., DNA methylation at the majority of which has been suggested to be consequential to BMI from a bidirectional MR analysis [14] . We analysed a DNA methylation score based on the 77 CpGs with a nominal P < 0.05 in our study. The DNA methylation score was calculated as the sum of the products of the DNA methylation Beta-value and the reported effect size of each CpG. The data for MZ pairs were used. The models were adjusted for age and cell proportions as was done in the association analyses. We let Y = the DNA methylation score and X = current BMI, i.e. the DNA methylation score is the outcome and current BMI is the predictor in regression models, and fitted the three models. We then let Y = current BMI and X = the DNA methylation score, i.e. the DNA methylation score is the predictor and current BMI is the outcome in regression models, and undertook the same analyses. We made statistical inference about the changes in regression coefficients by using a nonparametric bootstrap method to estimate the standard errors. Specifically, twin pairs were randomly sampled with replacement to generate 1000 new data sets with the same sample size as the original data set. ICE FALCON was then applied to each data set to calculate the change in regression coefficient for that data set. The standard error for the change in that coefficient was estimated by computing the standard deviation of the change across the 1000 data sets.
We applied ICE FALCON to CpGs and genes identified in our study. For each BMI trait, we similarly investigated DNA methylation at CpGs as a DNA methylation score. For a locus containing multiple CpGs, only the CpG with the smallest P-value was included in the DNA methylation score. BMI at age 18-21 years and its related DNA methylation was not investigated, given that the DNA methylation score was not correlated within MZ twin pairs (r = −0.07, 95% CI: −0.31, 0.17).
Results
Characteristics of the sample
For the women included in the analytic sample, the mean (standard deviation (SD)) age was 56.4 (7.9) years. The mean (SD) current BMI, BMI at age 18-21 years and BMI change was 26. Associations with CpG-specific DNA methylation DNA methylation at nine, six and 12 CpGs was found to be associated with current BMI, BMI at age 18-21 years and BMI change, respectively ( Table 1) . The genomic inflation factor λ was 1.10, 1.03 and 1.04 for current BMI, BMI at age 18-21 years and BMI change, respectively (Q-Q plots in Supplementary Figure 1 ; Manhattan plots in Supplementary Figure 2-4) . DNA methylation at two CpGs (cg12992827 and cg00636368) was negatively associated with both current BMI and BMI change. CpGs cg12992827 [10, 14] , cg18181703 [12] [13] [14] 16] , cg09349128 [10, 13, 14] , and the nucleotide-binding oligomerization domaincontaining 2 (NOD2) locus [13, 14, 16] have been reported previously. The other CpGs or loci have not been reported before.
Associations with gene-average DNA methylation
The average DNA methylation at the basic helix-loop-helix family member e40 (BHLHE40) and suppressor of cytokine signalling 3 (SOCS3) genes were both negatively associated with current BMI (BHLHE40: coefficient (coef) = −1.1 × 10 −3 , 95% CI: −1.5, −0.7, P = 3.8 × 10 −7 , FDR = 0.01; SOCS3: coef = −1.6 × 10 , so as well for standard error BMI body mass index, CpG cytosine-guanine dinucleotide, CHR chromosome, Coef coefficient, SE standard error, FDR false discovery rate Supplementary Figure 5) . Associations for the SOCS3 [12] [13] [14] [15] and PHGDH [9, [12] [13] [14] [15] genes have been previously reported, and for the BHLHE40 gene has not been reported before. DNA methylation at seven, five and five CpGs annotated to the BHLHE40, SOCS3 and PHGDH genes were associated with their respective BMI trait with a nominal P < 0.05, respectively (Supplementary Figure 6-8) .
Replication of previously reported associations
Altogether, 151 CpG associations were replicated with a nominal P < 0.05 and were in the same direction as that from previous studies, and the 59 most significant CpGs also had a FDR < 0.05 (Supplementary Table 1 ). A total of 41 gene associations were replicated with a nominal P < 0.05, and the six most significant genes also had a FDR < 0.05 (Supplementary Table 2 ).
Causal inference analyses results
The ICE FALCON results for CpGs reported by Wahl et al. [14] are shown in Table 2 . From the analyses with BMI as the predictor and the DNA methylation score as the outcome, a woman's DNA methylation score was associated with her own BMI (Model 1; β self = 0.96, 95% CI: 0.45, 1.47) and with her co-twin's BMI (Model 2; β co-twin = 0.57, 95% CI: 0.06, 1.08). Conditioning on her co-twin's BMI (Model 3), β′ self remained unchanged (P = 0.93), while conditioning on her own BMI (Model 3), β′ co-twin attenuated by 95.5% (95CI: 7.0%, 181.2%; P = 0.03) to be 0.03 (95% CI: −0.50, 0.55). From the analyses with the DNA methylation score as the predictor and BMI as the outcome, a woman's BMI was associated with her own DNA methylation score (Model 1; β self = 0.78, 95% CI: 0.14, 1.41) but not with her co-twin's DNA methylation score (Model 2; β co-twin = −0.02, 95% CI: −0.33, 0.30). In Model 3, β′ self remained unchanged (P = 0.16) compared with β self in Model 1, and β′ co-twin increased by 2500.0% (95%CI: 622.2%, 5044.3%; P = 0.03) compared with β co-twin in Model 2 to be 0.38 (95% CI: −0.01, 0.77). These results are consistent with the findings by Wahl et al. that DNA methylation at these CpGs is consequential to BMI.
Similarly, the results for CpGs identified in our study are consistent with the hypothesis that current BMI and BMI change have a causal effect on DNA methylation at their related CpGs, respectively ( Table 2 ). The same causation was inferred for gene-average DNA methylation (Supplementary Table 3 ). ICE FALCON, inference about causation through examination of familial confounding CpG cytosine-guanine dinucleotide, BMI body mass index, Est estimate, SE standard error a Regression coefficient from the analyses in which DNA methylation score as the predictor was reported as coefficient × 10, so as well for standard error
Discussion
We performed an EWAS between BMI traits and blood DNA methylation, and found that DNA methylation at several loci was associated with BMI at middle age, BMI at age 18-21 years and BMI change. DNA methylation at some of these loci, zona pellucida like domain-containing 1 (ZPLD1) [10, 14] , SOCS3 [12] [13] [14] [15] [16] , cysteine rich with EGF like domains 2 (CRELD2) [10, 13, 14] , NOD2 [13, 14, 16] , and PHGDH [9, 13, 14, 16] , has been previously reported to be associated with BMI. Associations at the other loci, such as lymphocyte antigen 9 (LY9), collagen type VI alpha 2 (COL6A2), zinc finger B-box domain-containing (ZBBX), mitogen-activated protein kinase kinase kinase 13 (MAP3K13), corticotropin-releasing hormone (CRH), etc. do not appear to have been previously reported. We replicated the associations for 151 CpGs and 41 genes reported by previous studies. The investigation of causation suggests that BMI and BMI change both have a causal effect on DNA methylation, but not vice versa. Several of the identified loci are involved in inflammatory pathways, which are biologically relevant to obesity: obesity-induced stimuli such as excess nutrients and adipocyte hypertrophy are thought to induce chronic inflammation [35] [36] [37] . LY9 is involved in regulation of the development of thymic innate memory-like CD8+T cell [38] and interleukin-17 production [39] . MAP3K13 is involved in activation of mitogen-activated protein kinases [40] . It has also been found to regulate NF-κB transcription factor activity [41] . NOD2 is involved in immune response by playing roles in several biological pathways, such as MAPK activation [42] , cytokine production [43] [44] [45] and NF-κB activation [46, 47] . SOCS3 plays a role in regulation of inflammatory response by negatively regulating cytokine signalling. It is also involved in the Gene Ontology (GO) pathway for negative regulation of insulin receptor signalling (GO:0046627). CRH is a member of the corticotropinreleasing factor family. It is included in the GO pathway for inflammatory response (GO:0006954). Previous studies have also reported DNA methylation at loci involved in inflammatory pathways to be associated with BMI [9, 10, [12] [13] [14] [15] [16] .
Some of the identified loci are related to other pathways, for which the relationships with obesity are less clear. Three loci are involved in oxidation reduction process. NAD kinase (NADK) is a NAD+kinase, which catalyses the reduction process from NAD to NADP. Crystallin zeta like 1 (CRYZL1) gene encodes quinone oxidoreductase and is involved in oxidation reduction process. Protein encoded by PHGDH is a member of oxidoreductase family. Two loci are involved in serine metabolism. Unc-51 like kinase 4 (ULK4) is a serine/threonine kinase. PHGDH is involved in the early steps of L-serine synthesis. Associations between DNA methylation at loci related to serine metabolism and BMI have also been reported by previous studies [9, 13, 16] .
Our study provides evidence for causation underlying the BMI-DNA methylation association. We replicated the finding of the causal effect that BMI has on DNA methylation at CpGs reported by Wahl et al. [14] . We found evidence consistent with differential DNA methylation at our identified CpGs being secondary to BMI, but not vice versa. Findings from previous studies [8, 13, 48 ] also support such a causal relationship. Inflammation is proposed to play a role in the development of some obesity-related diseases [35] [36] [37] , and several of the previously reported and our discovered loci are involved in inflammatory pathways; our findings imply that DNA methylation might mediate the effects of obesity on obesity-related diseases. To the best of our knowledge, research articles reporting this mediating role are lacking. An abstract reported that DNA methylation at 32 CpGs mediated up to 17% of the effect of obesity on fasting insulin [49] . There are several challenges, for which attention need to be given, in mediation investigation using high-dimensional omic data [50] ; formal research on this mediating role with a careful design is warranted.
Our study demonstrates the utility of ICE FALCON for investigation of causation underlying epigenetic associations. ICE FALCON shares similarities with a bidirectional MR approach. In the scenario represented by the Fig. 1b , we essentially use S X as an instrumental variable for X self . However, S X is not measured, so we use X co-twin as a surrogate instrumental variable (Similarly, Y co-twin is used as a surrogate for S Y , the instrumental variable for Y self , when the roles of Y and X are swapped). S X includes all causes of familial correlation in X that are specific to X, which is stronger than a limited number of genetic variants that are assumed to be specific to X, thus the results from ICE FALCON are less biased by the strength of the instrumental variable. S X , by definition, is not associated with confounders of the relationship between X and Y within an individual and has no directional pleiotropy (any association or directional pleiotropy has already been captured in S XY ). Even though the surrogate instrumental variable X cotwin is associated with the confounders or has directional pleiotropy, ICE FALCON still operates. For example, in a scenario where the association between X co-twin and Y self is mediated not only through S X and X self but also through other unmeasured factors such as familial confounders (i.e. a mixture of Fig. 1a, b) , even though X co-twin is still associated with Y self after adjusting for X self , β co-twin is still expected to attenuate towards the null, given that adjusting for X self blocks the pathway X co-twin ← S X → X self → Y self . ICE FALCON can be an alternative method for investigating causation when genetic variant data are unavailable, or the assumption underlying MR analyses are suspect. ICE FALCON can also be used as an independent method to replicate the findings from MR analyses, and vice versa. However, requirements such as the need for substantial within-pair correlations may limit the application of ICE FALCON, which was the case for BMI at age 18-21 years in our study.
Note that results from ICE FALCON should be interpreted with caution, because modelling alone cannot prove causation. ICE FALCON considers the extent to which data are consistent with different scenarios based on specified causal models. ICE FALCON, therefore, cannot prove that any one model is a true representation of nature but it can be used to test hypotheses and thereby has the potential to falsify model(s). For example, the bivariate classic twin model assumes there are no causal effects between the measured variables (Fig. 1a) . Our analyses show that this assumption is not substantiated because the observed regression coefficients differ to those expected under the classical twin model. Therefore, there is evidence against the null hypothesis of no causation, and our analyses suggest one plausible explanation for the data is that at least part of the association between BMI and DNA methylation is due to a causal effect of BMI, and not vice versa.
Our gene-average DNA methylation approach is of potential utility for analysing EWAS. Such utility is supported to some extent by our replication of previously reported genes including SOCS3 and PHGDH. A CpG-byCpG approach is typically used in EWAS. However, this approach requires a stringent genome-wide significance level, e.g. 10 −7 when half a million CpGs are analysed and the Bonferroni adjustment is applied, which may not be achievable. The gene-based approach aimed to address this challenge by reducing the number of tests to 20,000. This approach can potentially find novel associations missed by the CpG-by-CpG approach, such as the association for BHLHE40. Our study has several strengths. We studied three BMI traits at different life points. We used a novel family-based analytical approach to investigate the causation underlying the cross-sectional association and reached the same conclusion as the MR approach. We investigated gene-average DNA methylation, which can potentially provide evidence for novel associations.
One limitation of our study is that BMI traits were selfreported, thus are subject to recall bias. Another limitation is that we studied DNA methylation in peripheral blood, not in tissues more relevant to adiposity such as adipose tissue. However, cross-tissue investigations suggest moderate to good overall consistency between blood and adiposityrelevant tissues in the context of BMI-DNA methylation association. In the study by Demerath et al., associations for 64% of CpGs identified in blood were replicated in adipose tissue [10] . In the study by Wahl et al., blood DNA methylation levels at BMI-related CpGs had moderate to high correlations with DNA methylation levels in adiposityrelevant tissues [14] . More importantly, given that peripheral blood samples are easily accessible, any association with BMI detectable in this sample is potentially valuable for large-scale public health translation at a population level.
In conclusion, we found evidence that in peripheral blood from middle-aged women, DNA methylation at several loci is associated with current BMI, BMI at age 18-21 years and BMI change between the two ages. Additionally, our study found evidence consistent with BMI having a causal effect on peripheral blood DNA methylation.
